References Cited

Albuquerque, A., Rios, E., & Schmitt, F. (2019). Recommendations favoring anal cytology as a
method for anal cancer screening: a systematic review. Cancers, 11(12), 1942.

Bogdanova, A., Andrawos, C., & Constantinou, C. (2022). Cervical cancer, geographical
inequalities, prevention and barriers in resource depleted countries (Review). Oncology
Letters, 23(4), 113.

Cancer Research UK. (2023). Cervical Screening Results.

CIMIT. (2023, October). Guidance and Impact Tracking System (GAITS).

Clarke, M. A., & Wentzensen, N. (2018). Strategies for screening and early detection of anal
cancers: A narrative and systematic review and meta-analysis of cytology, HPV testing,
and other biomarkers. Cancer Cytopathology, 126(7), 447–460.

Colón-López, V., Shiels, M. S., Machin, M., Ortiz, A. P., Strickler, H., Castle, P. E., Pfeiffer, R.
M., & Engels, E. A. (2018). Anal cancer risk among people with HIV infection in the United
States. Journal of Clinical Oncology, 36(1), 68.

de Martel, C., Plummer, M., Vignat, J., & Franceschi, S. (2017). Worldwide burden of cancer
attributable to HPV by site, country and HPV type. International Journal of Cancer, 141(4),
664–670.

Fernandez, E. (2021, October 7). Treating Anal Cancer Precursor Lesions Reduces Cancer
Risk for People With HIV. UCSF News Center.

Fleming, K. A., Naidoo, M., Wilson, M., Flanigan, J., Horton, S., Kuti, M., Looi, L. M., Price, C.,
Ru, K., Ghafur, A., Wang, J., & Lago, N. (2016). An Essential Pathology Package for Low-
and Middle-Income Countries. American Journal of Clinical Pathology, aqw143.

Junaid, M., Suhail, A., Umer, B., Nawaz, A., Ikram, M., Sobani, Z.-A., & Ali, N. S. (2013).
Toluidine blue: yet another low cost method for screening oral cavity tumour margins in
third world countries. JPMA. The Journal of the Pakistan Medical Association, 63(7), 835–
837.

Land, K. J., Boeras, D. I., Chen, X.-S., Ramsay, A. R., & Peeling, R. W. (2019). REASSURED
diagnostics to inform disease control strategies, strengthen health systems and improve
patient outcomes. Nature Microbiology, 4(1), 46–54.

Office on Women’s Health. (2021). Pap and HPV Tests.

Palefsky, J. M., Lee, J. Y., Jay, N., Goldstone, S. E., Darragh, T. M., Dunlevy, H. A., Rosa-
Cunha, I., Arons, A., Pugliese, J. C., Vena, D., Sparano, J. A., Wilkin, T. J., Bucher, G.,
Stier, E. A., Tirado Gomez, M., Flowers, L., Barroso, L. F., Mitsuyasu, R. T., Lensing, S. Y.,
… Berry-Lawhorn, J. M. (2022). Treatment of Anal High-Grade Squamous Intraepithelial
Lesions to Prevent Anal Cancer. New England Journal of Medicine, 386(24), 2273–2282.

Perkins, R. B., Guido, R. S., Castle, P. E., Chelmow, D., Einstein, M. H., Garcia, F., Huh, W. K.,
Kim, J. J., Moscicki, A.-B., Nayar, R., Saraiya, M., Sawaya, G. F., Wentzensen, N., &
Schiffman, M. (2020). 2019 ASCCP Risk-Based Management Consensus Guidelines for
Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower
Genital Tract Disease, 24(2), 102–131.

Reiche, M. A., Warner, D. F., Aaron, J., Khuon, S., Fletcher, D. A., Hahn, K., Rogers, K. L.,
Mhlanga, M., Koch, A., Quaye, W., & Chew, T.-L. (2021). Imaging Africa: a strategic
approach to optical microscopy training in Africa. Nature Methods, 18(8), 847–855.

Richel, O., Prins, J. M., & de Vries, H. J. C. (2014). Screening for anal cancer precursors: what
is the learning curve for high-resolution anoscopy? Aids, 28(9), 1376–1377.

Silvera, R., Martinson, T., Gaisa, M. M., Liu, Y., Deshmukh, A. A., & Sigel, K. (2021). The other
side of screening: predictors of treatment and follow-up for anal precancers in a large
health system. AIDS, 35(13), 2157–2162.

Wilson, M. L., Fleming, K. A., Kuti, M. A., Looi, L. M., Lago, N., & Ru, K. (2018). Access to
pathology and laboratory medicine services: a crucial gap. The Lancet, 391(10133), 1927–
1938.

World Health Organization. (2024). Global Cancer Burden Growing Amidst Mounting Need For
Services.

World Health Organization. (2021). WHO guideline for screening and treatment of cervical pre-
cancer lesions for cervical cancer prevention 2nd Edition.